Siesta Medical, Inc. , a developer of minimally invasive surgical  solutions for obstructive sleep apnea (OSA), announced today that it has  received FDA 510(k) clearance for its Encore™ Tongue Suspension System for the  treatment of obstructive sleep apnea.  Obstructive sleep apnea (OSA) is a major heath problem in the United States.  As many as 17 million people in the United States have moderate to severe OSA,  which is characterized by frequent awakening during sleep, heavy snoring and  daytime sleepiness. If left untreated, OSA has been implicated in the increased  risk for cardiovascular disease, including hypertension and heart failure.  Despite its prevalence and role as a cardiovascular risk factor, OSA remains  largely under diagnosed. Read the rest of this entry

Are you sleeping too much or too less during nights? Research concluded in recent past has revealed that inflammation could play a key role in your health condition in such a situation.

Long and short duration sleep has been reported to have an increased risk for several disorders and health problems including coronary heart diseases, diabetes, obesity, and death in many of the previously concluded researches and studies. Inflammation regulating cytokines elevations have been found to have direct linkage with enhanced risk of health problems like heart disease and diabetes.

In this study where 614 participants reported their sleep habits after spending a night in sleep lab the mean self-reported sleep duration was calculated to be only 7.6 hours. The sleep lab reported sleep duration was only 6.2 hours on the contrary. Read the rest of this entry

Sleep Disorders Affect 40 Percent Canadians

Sleep disorders, like sleep apnea and insomnia, affect 40 per cent of Canadians, according  to new figures from a Laval University study published in this month’s issue of  the Canadian Journal of Psychiatry.

Through a survey of 2,000 people across Canada, researchers found 40 per cent  of respondents experienced symptoms of insomnia at least three times a week.  Symptoms include taking longer than 30 minutes to fall asleep, being awake  during the night for more than 30 minutes, or waking up at least 30 minutes  earlier than planned.

Although 20 per cent of respondents said they were unsatisfied with the  quality of their sleep, only 13 per cent of survey respondents say they visited  a doctor or health-care professional about the problem. Read the rest of this entry

In advance of a sleep apnea testing requirement by U.S. regulators, Harvard researchers are investigating a new type of screening tool to identify drivers at a higher risk for obstructive sleep apnea (OSA).

The psychomotor vigilance test is a 10-minute test of attention, alertness, and reaction time (RT). It can be accomplished within a short office visit, requires only brief instruction, is performed on portable, hand-held computers, and its output can be easily and quickly read and interpreted.

“Our goal is to develop objective screening methods beyond obesity for obstructive sleep apnea to be used in occupational health settings,” said the study’s senior author, Stefanos N. Kales, MD, MPH, Division Chief & Medical Director of Employee and Industrial Medicine at Cambridge Health Alliance. “Subjective reports of excessive daytime sleepiness are notoriously unreliable especially during fitness-for-work examinations, and obesity in isolation as a screen has generated resistance from many drivers.” Read the rest of this entry

Majority of pediatricians are not properly trained to advise parents or guardians on sleep hygiene for their children, according to new research published online August 28 and in the September print issue of Pediatrics.

As many as 33% of preadolescents and 40% of adolescents report experiencing some form of sleep problems, including sleep apnea, snoring, and sleep difficulty, according to lead author Firoza Faruqui, DO, from the Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Ohio, and colleagues. Sleep issues as seemingly benign as snoring have been linked in studies to lower academic performance and higher body mass index in early childhood, and sleep apnea has been linked to issues ranging from difficulties in social and emotional development to cardiac problems. Read the rest of this entry

Childhood Obstructive Sleep Apnea Syndrome

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations, polysomnographic findings, diagnostic criteria and treatment approaches need to be considered in an age-specific manner. Childhood OSAS has now become widely recognized as a frequent disorder and as a major public health problem. Pediatric OSAS, particularly when obesity is concurrently present, is associated with substantial end-organ morbidities and increased healthcare utilization. Although adenotonsillectomy (T&A) remains the first line of treatment, evidence in recent years suggests that the outcomes of this surgical procedure may not be as favorable as expected, such that post-T&A polysomnographic evaluation may be needed, especially in high-risk patient groups. In addition, incorporation of nonsurgical approaches for milder forms of the disorder and for residual OSAS after T&A is now being investigated. Read the rest of this entry

WideMed Ltd.  has obtained EU CE Mark for its mobile sleep apnea system Morpheus Ox for home use. The system is based on a device made by Nonin Medical Inc. and WideMed’s mobile application and Morpheus platform for monitoring sleep apnea.

The device’s interface receives photoplethysmography (PPH) signals, which are collated by an application developed by the company for mobile telephones.

The Morpheus Ox system can monitor, measure, and analyze snores and send accurate data to a physician about the patient’s respiration, sleep apnea, oxygen levels, and heartbeat during the night.

WideMed said that it plans to begin marketing the Morpheus Ox system in Europe and the Far East during the fourth quarter, and that it undergoing regulatory procedures with the Food and Drug Administration (FDA) to approve the device for marketing in the US.

Acute coronary syndrome (ACS) during sleep occurs at a relatively low frequency and the pathogenic background remains uncertain. The aim of a recently concluded study was to determine the significance of sleep-disordered breathing (SDB) and excess visceral fat with nocturnal dysregulation of adipocytokines in night-time onset of ACS.

SDB, visceral fat area (VFA), and changes in circulating adipocytokine levels were assessed in 109 consecutive patients with ACS. SDB and VFA were assessed by cardiorespiratory monitoring and computed tomographic scan, respectively. Read the rest of this entry

The Best Sleeping Positions

Good night’s sleep is important for numerous health benefits. The best position is to sleep on your back, according to a new study.

It prevents neck and back pain, reduces acid reflux and minimizes wrinkles. Sleeping on your back makes it easy for your head, neck and spine to maintain a neutral position.

However, people with severe snoring or sleep apnea should avoid sleeping on their back. This position is recommended for people with neck pain along with a cervical roll or pillow.

The next best position is the side position. This position is great for your overall health. It prevents neck and back pain, reduces acid reflux and reduces snoring. This position is ideal for women who are pregnant. Women in late pregnancy should sleep on their left side to increase blood flow to the baby. Side sleeping keeps your spine elongated preventing back soreness. Read the rest of this entry

The Aviisha Medical Institute, LLC is making headway in the battle against sleep apnea as physician groups continue to join its MD Home Sleep Program at a record pace. The program equips physicians with the knowledge and tools to diagnose and treat sleep apnea without resorting to costly lab testing.

The surge in group signups has helped Aviisha, the national leader in home sleep testing, reach more sleep apnea patients than ever before. “We’re seeing a remarkable number of patients getting treated thanks to the collective effort of our physicians,” said Dr. Avi Ishaaya, the cofounder and Medical Director of Aviisha. “Only 10-20% of sufferers are diagnosed despite the fact that untreated sleep apnea has such devastating health consequences.” Sleep apnea has been linked to increased risk of stroke, diabetes, heart failure, hypertension, obesity, sexual dysfunctional, depression, loss of motivation, and chronic fatigue.”

The groups come from a variety of states and comprise numerous specialties.

Aviisha’s MD Home Sleep Program Read the rest of this entry

Related Posts with Thumbnails